Evidence map›Paper›PMID 42212701›Full record

ReviewCancer science2026

Interpreting Early-Onset Colorectal Cancer in Japan: A Descriptive Epidemiologic Review Using Public Summary Statistics.

Keitaro Matsuo, Hidemi Ito

Abstract readReview
In one paragraph

Review in Cancer science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Keitaro MatsuoDivision of Cancer Epidemiology and Prevention, Aichi Cancer Center, Nagoya, Aichi, Japan.ORCID https://orcid.org/0000-0003-1761-6314
Hidemi ItoDivision of Cancer Information and Control, Aichi Cancer Center, Nagoya, Aichi, Japan.ORCID https://orcid.org/0000-0002-8023-4581

Funding

Aichi Cancer Center Joint Research ProjectMinistry of Health, Labour and Welfare 23EA1033Ministry of Health, Labour and Welfare 26EA0101
6 · The paper itself

Abstract

Early-onset colorectal cancer (EOCRC) is increasingly described as a rising disease entity, but the descriptive epidemiologic conditions required to interpret that rise remain incompletely articulated. Using Japanese public summary statistics, we conducted a reproducible descriptive epidemiology review to examine whether the observed EOCRC signal is more compatible with substantial detection-related effects, a concurrent increase in invasive burden, or both. We integrated age-group-specific incidence and mortality trends and, where available, decomposed incidence into invasive disease, incidence including in situ lesions, and the in situ component. Colorectal cancer was the primary case study, and other organized screening-target cancers were used as descriptive contrasts. In Japan, EOCRC showed increasing early-onset-to-older-adult incidence ratios, but these patterns should be interpreted alongside marked in situ amplification and limited concordance with mortality. Cross-cancer contrasts further aided interpretation: Unlike CRC, stomach cancer and male lung cancer did not show a comparable early-onset upswing over the 2003-2015 comparison window, arguing against a uniform early-onset pattern across screening-target cancers. These descriptive findings are compatible with substantial detection-related effects, but they do not exclude biologic heterogeneity or a concurrent increase in invasive EOCRC. Although public summary statistics cannot establish etiology, they can clarify what current trend data do and do not support. In particular, incidence trends alone are insufficient to justify a true-rise interpretation of clinically significant early-onset colorectal cancer.

Indexed as

Colorectal NeoplasmsAdultAgedAge of OnsetEarly Detection of CancerFemaleHumansIncidenceJapanMaleMiddle Agedcancer registrydescriptive epidemiologyearly‐onset colorectal cancerincidencemortality

Identifiers

PMID42212701
PMCPMC13394062

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.